{"id":579,"date":"2025-11-17T13:14:26","date_gmt":"2025-11-17T21:14:26","guid":{"rendered":"https:\/\/www.leapfrog.bio\/?page_id=579"},"modified":"2025-11-17T15:09:14","modified_gmt":"2025-11-17T23:09:14","slug":"partnering","status":"publish","type":"page","link":"https:\/\/www.leapfrog.bio\/fr\/partnering\/","title":{"rendered":"Devenir partenaire"},"content":{"rendered":"

<\/div>

Partnering<\/h1>\n<\/div><\/div><\/div><\/div><\/div>
<\/div>
<\/span><\/div><\/div><\/div>

Partnering<\/h2>\n<\/div>
<\/span><\/div>

At Leapfrog Bio, we collaborate with pharmaceutical and biotechnology companies to unlock hidden value from shelved or deprioritized assets by applying our OncoSLX platform to identify new, genetically defined patient populations.<\/p>\n

We offer a range of flexible partnership models tailored to the needs of our collaborators, including:<\/p>\n

    \n
  • Portfolio screening and target matching using our OncoSLX Platform to identify compounds with potential in novel oncology indications<\/li>\n
  • R&D libraries and discovery-stage assets<\/li>\n<\/ul>\n

    We actively evaluate:<\/p>\n

      \n
    • Pre-clinical and clinical product candidates that may benefit from genetic retargeting<\/li>\n
    • R&D libraries and discovery-stage assets<\/li>\n
    • Shelved or legacy programs with unrealized oncology applications<\/li>\n<\/ul>\n<\/div>

      Please contact bd@leapfrog.bio<\/a> for more information.<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div>

      Locations<\/h2>\n<\/div>

      Corporate Office<\/strong>
      \n400 Oyster Point Boulevard, Suite 203
      \nSouth San Francisco, CA 94080<\/p>\n

      Research & Development Labs<\/strong>
      \n2300 Boul Alfred Nobel
      \nSaint-Laurent, QC H4S 2A4<\/p>\n

      General Inquiries: <\/strong>
      \n      contact@leapfrog.bio<\/a><\/p>\n

      Business Development & Partnering:<\/strong>
      \n      bd@leapfrog.bio<\/a><\/p>\n<\/div><\/div><\/div>